Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Public ClinicalTrials.gov record NCT05314738. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Study identification
- NCT ID
- NCT05314738
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Glaukos Corporation
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- NXL Energy 1 Combination Product
- NXL Energy 2 Combination Product
- NXL Energy 3 Combination Product
- Sham Treatment Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 7, 2022
- Primary completion
- Jul 31, 2025
- Completion
- Jan 31, 2026
- Last update posted
- Jul 7, 2024
2022 – 2026
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Glaukos Investigative Site | Dothan | Alabama | 36301 | Recruiting |
| Glaukos Investigative Site | Teaneck | New Jersey | 07666 | Recruiting |
| Glaukos Investigative Site | Westerville | Ohio | 43082 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05314738, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05314738 live on ClinicalTrials.gov.